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Background Vascular endothelial growth factor VEGF is known to be associated with the pathogenesis of chronic rhinosinusitis with nasal polyps CRSwNP . VEGF is produced by a variety of cells including fibroblasts. It was recently reported that prostaglandin PG E induces VEGF release by nasal polyp fibroblasts. However, little is known regarding possible regulation of VEGF by other PGs. We have reported that molecules that regulate PGD metabolism play roles in the pathogenesis of CRS including in local eosinophilia and type cytokine production. In the present study, we sought to determine whether PGD regulates VEGF release by nasal polyp fibroblasts.
Methods
Nasal polyp fibroblasts were established from nasal polyps. These fibroblasts were stimulated with serial dilutions of PGD or PGD receptor DP/CRTH -selective agonists in the presence or absence of receptor-selective antagonists.
The concentration of VEGF in the culture supernatants was determined using ELISA. These results suggest that blockage of CRTH receptor signaling augments DP receptor signaling, which then enhances VEGF release in nasal polyp fibroblasts. The lack of dose-dependent effect by PGD but not DP receptor-selective agonist on VEGF release may be due to the stimulation of CRTH receptor by high concentration of PGD .
Results

Conclusions
DP was dominantly expressed in nasal polyp fibroblasts as compared with CRTH . PGD stimulates VEGF production via DP but not CRTH receptor in nasal polyp fibroblasts. The DP receptor-selective antagonists inhibited PGD -induced release of VEGF in a dose-dependent manner.
Thus, DP receptor may be a target for controlling CRS with nasal polyps.
